- Home
- CERS vs NPCT Comparison
CERS vs NPCT Comparison
Compare CERS & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- NPCT
- Stock Information
- Founded
- CERS 1991
- NPCT 2020
- Country
- CERS United States
- NPCT United States
- Employees
- CERS N/A
- NPCT N/A
- Industry
- CERS EDP Services
- NPCT Investment Managers
- Sector
- CERS Technology
- NPCT Finance
- Exchange
- CERS Nasdaq
- NPCT Nasdaq
- Market Cap
- CERS 347.3M
- NPCT 308.5M
- IPO Year
- CERS 1997
- NPCT N/A
- Fundamental
- Price
- CERS $1.65
- NPCT $10.85
- Analyst Decision
- CERS Buy
- NPCT
- Analyst Count
- CERS 3
- NPCT 0
- Target Price
- CERS $3.17
- NPCT N/A
- AVG Volume (30 Days)
- CERS 1.6M
- NPCT 107.1K
- Earning Date
- CERS 02-20-2025
- NPCT 01-01-0001
- Dividend Yield
- CERS N/A
- NPCT 9.82%
- EPS Growth
- CERS N/A
- NPCT N/A
- EPS
- CERS N/A
- NPCT N/A
- Revenue
- CERS $180,270,000.00
- NPCT N/A
- Revenue This Year
- CERS $15.95
- NPCT N/A
- Revenue Next Year
- CERS $10.50
- NPCT N/A
- P/E Ratio
- CERS N/A
- NPCT N/A
- Revenue Growth
- CERS 15.29
- NPCT N/A
- 52 Week Low
- CERS $1.38
- NPCT $8.58
- 52 Week High
- CERS $2.59
- NPCT $10.63
- Technical
- Relative Strength Index (RSI)
- CERS 41.40
- NPCT 55.61
- Support Level
- CERS $1.64
- NPCT $10.76
- Resistance Level
- CERS $1.96
- NPCT $10.97
- Average True Range (ATR)
- CERS 0.11
- NPCT 0.07
- MACD
- CERS -0.02
- NPCT -0.00
- Stochastic Oscillator
- CERS 3.12
- NPCT 56.99
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.